LYLinwah Yip

Linwah Yip

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Linwah Yip has a total of 173 co-authors. Here are the top co-authors by number of shared publications:

  • Sally E. Carty

    The University of Pittsburgh Pittsburgh Pennsylvania USA

    39 shared publications
  • Kelly L. McCoy

    Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, PA

    28 shared publications
  • Michael T. Stang

    Department of Surgery, Division of Endocrine Surgery, University of Pittsburgh, Pittsburgh, PA

    14 shared publications
  • Yuri E. Nikiforov

    Division of Molecular and Genomic Pathology, Department of Pathology, University of Pittsburgh, PA

    13 shared publications
  • Steven P. Hodak

    Department of Medicine, Division of Endocrinology, University of Pittsburgh, Pittsburgh, PA

    11 shared publications
  • Marina N. Nikiforova

    Division of Molecular and Genomic Pathology, Department of Pathology, University of Pittsburgh, PA

    10 shared publications

Latest Publications

  • Clinical and Molecular Predictors of Malignancy in a Series of 585 RAS-positive Thyroid Nodules with Surgical Outcome

    by William R Doerfler, Andrea Santos Argueta, Alyaksandr V Nikitski, Alaa Sada, Saba Kurtom, Jason B Liu, Linwah Yip, Yuri E Nikiforov

    Context: RAS mutations are detected in a wide spectrum of thyroid tumors and when found on FNA biopsy, surgery is typically indicated. Objective: To identify clinical and molecular predictors of malignancy or non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in a consecutive series of RAS-positive thyroid nodules with known surgical outcome. Methods: We performed a single institution retrospective analysis of a consecutive series of RAS-positive thyroid nodules detected using ThyroSeqv3 and with either histopathology or ≥1 year follow-up ultrasound (2018-2024). Results: Totally, 585 RAS positive nodules with surgical pathology and 55 non-resected nodules were identified. After surgery 140/585 (24%) of nodules were benign, 149/585 (25%) NIFTP, and 296/585 (51%) cancer. The rate of cancer/NIFTP was lower in nodules with isolated KRAS mutations (34%) compared to isolated NRAS (74%) or HRAS (81%) (p<0.0001). The presence of copy number alterations (CNA) (OR 12, p=0.02), nodule size on ultrasound (OR 1.3, p=0.003) and higher Bethesda classification (IV, V or VI) were associated with cancer/NIFTP on multivariable analysis. On median follow-up of 2.5 years (IQR 1.2-4), persistent/recurrent disease occurred in 19/272 (7%) patients with a cancer diagnosis and was more likely with concurrent high-risk mutations (14/28, 50%) vs without (5/244, 2%), p<0.0001, with an even lower rate among isolated RAS cancers (1/133, 0.8%). After median 2.3 years (IQR 1.5-4.5), 6/55 nodules (11%) had significant growth. Conclusions: In this large series of RAS-positive tumors molecular and clinical factors predicted cancer. In isolated RAS-positive tumors, the rate of recurrent/persistent disease was very low with low rates of significant growth in non-resected nodules, suggesting that these nodules may be managed with lobectomy, and in select cases, even non-surgically.

  • IGF2BP3-Overexpressing Follicular Cell-derived Thyroid Tumors Consist of Low-risk Follicular Patterned Tumors with Frequent HBME-1 Negativity and Distinct Cytomorphologic Features

    by André Lametti, Diana Bell, Simion I. Chiosea, Elena Morariu, Kelly McCoy, Linwah Yip, Yuri E. Nikiforov, Raja R. Seethala

  • Learner and Teacher Entrustability Concordance in Endocrine Surgery Entrustable Professional Activities

    by Polina Zmijewski, Julia Adriana Kasmirski, Sanjana Balachandra, Chandler McLeod, Ramsha Akhund, Ashba Allahwasaya, Taylor Lafrinere, Jessica M. Fazendin, Sally E. Carty, Paul H. Graham, et al.

    Introduction: The American Association of Endocrine Surgeons (AAES) drafted Entrustable Professional Activities (EPAs) for Endocrine Surgery (ES) to assess general surgery residents and ES fellows in core topics. Here, we examine learner and teacher concordance of entrustability ratings. Methods: Fourteen EPAs were defined (10 “core”–6 with pre‐, intra‐, and post‐operative phases, four single‐phase–and four elective EPAs). Ten institutions collected three‐item micro‐assessments (MAs) of learner EPA performance using a web‐based platform, where entrustment was assessed on observable behaviors using a five‐point scale. Learner provided self‐assessment ratings, while teachers separately assigned ratings for the same activities. Spearman rank correlation tests were applied to compare learner‐teacher ratings for EPAs. Results: MAs ( n = 698) were submitted between 7/2022‐9/2023. Programs submitted between 3 and 468 MAs. Among 3‐phase core EPAs, the intraoperative phase was most assessed ( n = 496), followed by pre‐ and post‐operative phases ( n = 108 and 55, respectively). Thirty‐nine single‐phase EPAs were submitted. Learner self‐assessment and teacher ratings were equivalent for 32% of pre‐operative EPAs, 53% of intra‐operative EPAs, 29% of post‐operative EPAs, and 64% of single phase of care EPAs. Spearman rank correlation between teacher and learner ratings for all phases of care combined was 0.66. Correlation was highest for the intra‐operative phase (0.73), followed by single‐phase (0.65), pre‐operative phase (0.27), and post‐operative phase (0.20). Rating concordance did not differ when high and low scores were examined independently. Learners were more prone to underestimate performance than to overestimate it when ratings were discordant. Conclusions: Learners' self‐assessment and teacher ratings of endocrine surgery EPAs are strongly concordant with operative technical skills. However, learners often underestimate their performance of pre‐ and post‐operative care compared to faculty ratings when using EPAs.

  • Robot-assisted resection of retrocaval paraganglioma: technical considerations and approach

    by Kayleigh M. Herrick-Reynolds, Sebastiaan Ceuppens, Linwah Yip, Alessandro Paniccia

    Here, we present the case of a 27-year-old male with a known history of Von Hippel Lindau (vHL) syndrome who was found to have a recurrent paraganglioma in the retrocaval space after laparoscopic right partial adrenalectomy at age 16. He was referred for consideration of a minimally invasive approach to resection. This is particularly important in vHL patients as they are at a high risk of recurrence and need for additional surgical interventions over the course of their lifetime. The paraganglioma measured 3.8 cm and was positioned within the retrocaval/aortocaval space, fully posterior to the left renal vein and abutting the right renal hilum. The accompanying video demonstrates a step-by-step approach to this challenging dissection, as well as pertinent preoperative planning, intraoperative positioning, port placement, and retraction techniques for optimal visualization. We also demonstrated the authors preferred approach to managing minor bleeding within the confines of a small space to salvage a minimally invasive resection. The robotic-assisted platform led to complete resection, uncomplicated hospital course, and discharge home on postoperative day one.


  • The Landmark Series: Testing in Thyroid Nodule Fine Needle Aspiration Cytology

    by Kimberly M. Ramonell, Linwah Yip

    There has been remarkable growth in our understanding of the biologic behavior and molecular signature of thyroid malignancies, which has led to the introd


  • Entrustable Professional Activities in endocrine surgery: A national pilot study

    by Polina Zmijewski, M. Chandler McLeod, Ramsha Akhund, Ashba Allahwasaya, Taylor Lafrinere, Jessica M. Fazendin, Sally E. Carty, Paul Graham, David Hughes, Melanie Lyden, et al.


  • Reappraisal of BRAFK601E-positive thyroid tumors in the NIFTP era

    by William R Doerfler, Alyaksandr V Nikitski, Shannon Keating, Daniel Spagnolo, Cihan Kaya, Elena M Morariu, Esra Karslioglu French, Linwah Yip, Marina N Nikiforova, Abigail I Wald, et al.

    BRAFK601E is an uncommon mutation typically found in encapsulated follicular-patterned thyroid tumors. Previous studies on BRAFK601E-positive thyroid tumors were conducted before the implementation of the non-invasive follicular neoplasm with papillary-like nuclear features (NIFTP) diagnosis. This study aimed to characterize BRAFK601E-positive tumors and evaluate changes in the diagnosis and management of these patients after the introduction of NIFTP. We evaluated 25 thyroid tumors that were positive for BRAFK601E and diagnosed considering the NIFTP criteria. Clinicopathologic characteristics and recurrence rates of these tumors were compared to 29 BRAFK601E-positive tumors diagnosed prior to the acceptance of the NIFTP diagnosis. RNA-seq analysis was performed on 10 BRAFK601E-positive tumors. In the current study, 72% of BRAFK601E-positive tumors were diagnosed as non-invasive tumors on resection, with NIFTP (48% of all tumors) being the most common diagnosis. BRAFK601E-positive tumors exhibited a RAS-like gene expression profile with a BRAF-RAS score (BRS) and thyroid differentiation score (TDS) distinct from BRAFV600E-positive tumors (P < 0.001). Since 2016, patients with BRAFK601E-positive tumors less frequently underwent total thyroidectomy (41% vs 100%, P < 0.001) and received radioiodine (7% vs 75%, P < 0.001). None of the tumors positive for an isolated BRAFK601E mutation from the current or 2016 studies showed recurrences on follow-up. Our study demonstrates that most BRAFK601E-positive tumors are low-risk, RAS-like tumors, which were diagnosed as NIFTP in half of all study cases. Since 2016, patients with BRAFK601E-positive nodules have received less aggressive treatment. The risk of recurrence of BRAFK601E-positive tumors without other high-risk features appears to be low, and lobectomy without radioiodine is likely a sufficient treatment for these patients.


  • Open Access

    Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrence

    by Saba Kurtom, Jason B. Liu, William R. Doerfler, Michael Calcaterra, Kelly L. McCoy, Alaa Sada, Kimberly M. Ramonell, Sally E. Carty, Marina N. Nikiforova, Yuri E. Nikiforov, et al.